Early Use of Contrast in Cardiac Magnetic Resonance  by Higgins, Charles B.
HE
M
C
S
C
f
b
(
M
a
h
r
e
d
1
t
I
t
h
s
w
c
S
r
e
a
w
1
a
n
t
c
i
u
U
F
F
M
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 2 , N O . 2 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 0 8 . 0 7 . 0 1 7I S T O R I C A L P E R S P E C T I V E
arly Use of Contrast in Cardiac
agnetic Resonance
harles B. Higgins, MD
an Francisco, Californiaa
I
A
e
s
t
c
c
c
h
c
p
a
v
a
m
c
c
w
w
c
c
1
f
t
n
t
r
s
m
p
q
i
n
a
aomputed tomography (CT) was developed
or medical diagnosis more than a decade
efore the introduction of magnetic resonance
MR) imaging. Contrast media for CT and
R imaging have identical tissue distribution
nd plasma kinetics. So the story of the early
istory of contrast media for cardiac magnetic
esonance (CMR) actually starts with early
xperimental work with iodinated contrast me-
ia and prototype cardiac CT scanners in the
970s.
CT and MR imaging were rapidly accepted
o diagnose diseases of the brain and spine.
ndeed, within a few years after their introduc-
ion, these tomographic imaging techniques
ad already revolutionized precision in diagno-
is of neurologic diseases. On the other hand,
idespread adoption of these techniques for
ardiac diagnosis has required about 25 years.
ome of this delay in clinical application was
elated to delays in technologic advances nec-
ssary for overcoming the motion of breathing
nd cardiac contraction. Additionally, there
as a prevailing perception in the 1970s and
980s that echocardiography and nuclear im-
ging provided most information required from
oninvasive cardiac imaging. The promise of
issue characterization using CT and, espe-
ially, MR imaging was considered either un-
mportant for clinical cardiology or practically
nattainable.
In 1977 to 1978, our research group at the
niversity of California, San Diego, was
rom the Department of Radiology, University of California, San
rancisco School of Medicine, San Francisco, California.ianuscript received July 14, 2008, accepted July 21, 2008.warded research grants from the National
nstitutes of Health and the American Heart
ssociation to explore the use of contrast-
nhanced CT for tissue characterization of the
everity of ischemic myocardial injury. At that
ime, we were aware that available iodinated
ontrast media distributed rapidly in the extra-
ellular space and were excluded from viable
ells in most organs, including the heart. Our
ypothesis was that ischemic injury would
ause loss of cellular membrane integrity and
ermit entrance of contrast media into dam-
ged myocardial cells. The initial research in-
olved extirpation of canine hearts with acute
nd chronic myocardial infarctions at 5 to 30
in after intravenous injection of iodinated
ontrast media. Ex vivo CT imaging (electro-
ardiography [ECG] gating of CT scanners
as not available in 1977 to 1978) of the hearts
ith acute infarction demonstrated dramati-
ally higher density of the infarcted tissue
ompared with normal myocardium (1) (Fig.
). The hyperenhanced myocardial region con-
ormed to the site of increased uptake of
echnetium pyrophosphate (infarct-avid radio-
ucleotide) and the regional deficit of 201-
hallium distribution (2). The hyperenhanced
egion showed close correspondence with the
patial extent of myocardial infarction as de-
arcated by histochemical morphometry (tri-
henyl tetrazolium chloride [TTC]). Subse-
uently, the intracellular distribution of iodine
n infarcted tissue was confirmed using scan-
ing electron microscopy with X-ray dispersive
nalysis (3). Tissue samples obtained from
nimals with reperfused infarcts showed a sim-
lar myocardial spatial distribution of iodine
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242iodinated contrast media) and technetium-99m
yrophosphate; thallium-201 had a diametric dis-
ribution. Iodine and technetium-99m pyrophos-
hate had the greatest concentration in the center
f the infarct; a lower concentration at the periphery
uggested a border zone of ischemic injury (2). The
Figure 1. Ex Vivo Computed Tomographic Scans of a Canine He
The 1-cm thick transverse scans start at the apex (top) and extend
min after intravenous injection of iodinated contrast medium. Corre
tetrazolium chloride demarcate the infarcted region. The infarcted r
medium.
Transverse T1 Weighted Spin Echocardiographic Image of the
eart From a Dog With a 24-H-Old Myocardial Infarction
-diethylenetriaminepentaacetic acid was injected intravenously 5
sacriﬁce. The entire infarcted region has markedly greater signal
mpared with normal myocardium. Reprinted, with permission,U
mara et al. (8).yperenhancement of acute infarctions was shown
ater in the in situ beating heart using a prototype
lectrocardiographic (retrospective)-gated CT scanner
n the late 1970s (4).
The paucity of ECG-gated CT scanners (10 in
he world) capable of imaging the beating heart at
his time caused this information to have little
linical applicability. Indeed, the notion that per-
istent enhancement of myocardial infarctions on
omographic imaging could be used to assess myo-
ardial viability was not universally recognized until
everal years after the introduction of CMR.
MR imaging had a more favorable early history
or potential cardiovascular applications. Early
CG-gated MR imaging were produced within a
ew years after the introduction of MR imaging for
eurologic diagnoses. The first CMR images were
ublished in the early 1980s (5,6). Around the same
ime, the concept of preferential and persistent
nhancement of myocardial infarctions using gad-
linium chelates was established using MRI of
anine hearts extirpated at 5 min after administra-
ion of gadolinium contrast media (Fig. 2) (7,8).
hortly thereafter, the phenomenon of delayed
ontrast enhancement of acute myocardial infarc-
ions was demonstrated in the in situ canine heart
sing ECG-gated T1-weighted images (Fig. 3) (9).
With a 7-Day-Old Myocardial Infarction
he middle of the left ventricle (bottom). Heart was excised at 5
nding tracings of the ventricle slices after staining with triphenyl
n has higher density due to greater concentration of the contrastart
to t
spo
egioFigure 2.
Excised H
Gadolinium
min before
density cosing ECG-gated MRI of the intact animals, it
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243as also shown that differential distribution of
adolinium contrast media could distinguish be-
ween reperfused and nonreperfused myocardial
nfarction (9); this method could identify a no
eflow zone (microvascular obstruction). Early ani-
al studies using varying durations of ischemia
howed no delayed enhancement of reversibly in-
ured myocardium (ischemia of15 to 20 min), but
elayed enhancement only of irreversibly injured
yocardium (10,11).
Gadolinium-enhanced CMR imaging of isch-
mically injured myocardium was shown to be
ffective for estimating the severity of ischemic
yocardial injury (12,13). Using increasing dura-
ions of regional ischemia, the distribution volume
f the gadolinium chelate in the myocardium in-
reased. The distribution volume in normal myo-
ardium corresponded roughly to the extracellular
pace (approximately 20%); with complete necrosis,
he distribution volume approached 100% of the
Figure 3. Electrocardiography-Gated In Vivo T1-Weighted Magn
Two adjacent levels are shown: before (A and B) and after 5 min
taacetic acid (C and D). The 48-h-old myocardial infarction is de
high signal in the left ventricular cavity due to slowly ﬂowing bl
viation as in Figure 2.yocardium in the infarcted region. By quantifying the intensity of delayed gadolinium enhancement
nd estimating the regional myocardial distribution
olume, a gradient of necrosis could be discerned
rom the center to the periphery of the ischemic
one (14). This gradient matched the distribu-
ion of technetium-99m diethylenetriaminepenta-
cetic acid (DTPA), a radioactive surrogate of
adolinium-DTPA, on autoradiographic images of
0-m-thick cross-sectional slices of the rat heart.
The initial report documenting the occurrence of
ifferential gadolinium enhancement of myocardial
nfarctions in patients was reported in 1989 by de
oos et al. (15). The group also showed the
ifferent enhancement patterns in patients with
resumed occlusive compared with reperfused in-
arctions (16).
Improvements in CMR technology along with
he development of a sequence to greatly improve
ontrast between normal myocardium and infarc-
ions contributed greatly to clinical acceptance of
Resonance Images of a Heart
st-intravenous injection of gadolinium-diethylenetriaminepen-
cated on the contrast-enhanced images (arrows). *Indicates the
. Reprinted, with permission, from Tscholakoff et al. (9). Abbre-etic
po
mar
oodhe use of gadolinium-enhanced CMR for demon-
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244trating the presence, transmural extent, and size of
yocardial infarctions. This sequence of inversion
ecovery gradient echocardiographic imaging in or-
er to null normal myocardial signal provided enor-
ous contrast between the infarct and adjacent
ormal myocardium, increasing the ease and reli-
bility of image interpretation (17).
Several studies established the concept that this
echnique was a reliable one for distinguishing
ecrotic or scarred myocardium from viable myo-
ardium (18). Moreover, the concept of using theFL, Revel D, Sievers R, Brasch RC. agnostic potentialent of dysfunctional myocardial segments to pre-
ict late recovery of regional contractile function in
he follow-up of acute infarctions (19) or in re-
ponse to revascularization (20) has become one of
he most important applications of CMR in the
ast decade and remains so today.
eprint requests and correspondence:Dr. Charles B. Hig-
ins, UCSF School of Medicine, University of California,
an Francisco, Department of Radiology, 505 Parnassus
venue, Suite L-308, San Francisco, California 94143-transmural extent of delayed gadolinium enhance- 0628. E-mail: charles.higgins@radiology.ucsf.edu.1
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